Isomeric flavonoid aglycones derived from Epimedii Folium exerted different intensities in anti‐osteoporosis through OPG/RANKL protein targets

[1]  Vishvanath Tiwari,et al.  Investigation of the interaction of allergens of Glycine max with IgE‐antibody for designing of peptidomimetics based anti‐allergen , 2018, International immunopharmacology.

[2]  X. Guo,et al.  Abnormal microarchitecture and stiffness in postmenopausal women using chronic inhaled glucocorticoids , 2018, Osteoporosis International.

[3]  T. Vokes,et al.  Vertebral fracture assessment: Enhancing the diagnosis, prevention, and treatment of osteoporosis. , 2017, Bone.

[4]  C. von Buchwald,et al.  The risk of osteoporosis in oral steroid treatment for nasal polyposis: a systematic review. , 2017, Rhinology.

[5]  Qingxiang Zhong,et al.  Beneficial Effects and Toxicity Studies of Xian-ling-gu-bao on Bone Metabolism in Ovariectomized Rats , 2017, Front. Pharmacol..

[6]  J. B. Tyrovola,et al.  The “Mechanostat” Principle and the Osteoprotegerin—OPG/RANKL/RANK System PART II. The Role of the Hypothalamic—Pituitary Axis , 2017, Journal of cellular biochemistry.

[7]  S. Christin‐Maitre.  Use of Hormone Replacement in Females with Endocrine Disorders , 2017, Hormone Research in Paediatrics.

[8]  Lianghu Zhang,et al.  Treating osteoporotic vertebral compression fractures with intraosseous vacuum phenomena using high-viscosity bone cement via bilateral percutaneous vertebroplasty , 2017, Medicine.

[9]  P. Foster,et al.  Estrone Sulfate Transport and Steroid Sulfatase Activity in Colorectal Cancer: Implications for Hormone Replacement Therapy , 2017, Front. Pharmacol..

[10]  Tümay Sözen,et al.  An overview and management of osteoporosis. , 2017, European journal of rheumatology.

[11]  J. Tseng,et al.  Increased risk of breast cancer in women with uterine myoma: a nationwide, population-based, case-control study , 2017, Journal of gynecologic oncology.

[12]  J. Eden.  The endometrial and breast safety of menopausal hormone therapy containing micronised progesterone: A short review , 2017, The Australian & New Zealand journal of obstetrics & gynaecology.

[13]  P. Damas,et al.  Bone markers during acute burn care: Relevance to clinical practice? , 2017, Burns : journal of the International Society for Burn Injuries.

[14]  Yongjiang Wu,et al.  Rapid measurement of epimedin A, epimedin B, epimedin C, icariin, and moisture in Herba Epimedii using near infrared spectroscopy. , 2017, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[15]  S. Sacco,et al.  Repeated irradiation from micro-computed tomography scanning at 2, 4 and 6 months of age does not induce damage to tibial bone microstructure in male and female CD-1 mice. , 2017, BoneKEy reports.

[16]  Thijs Beuming,et al.  Investigating Protein-Peptide Interactions Using the Schrödinger Computational Suite. , 2017, Methods in molecular biology.

[17]  Noha I Hussien,et al.  A comparative study between the effect of 17-β estradiol and angiotensin converting enzyme inhibitor on osteoporosis in ovariectomized rats. , 2016, General physiology and biophysics.

[18]  Mengsu Yang,et al.  Flavonoids of Herba Epimedii stimulate osteogenic differentiation and suppress adipogenic differentiation of primary mesenchymal stem cells via estrogen receptor pathway , 2016, Pharmaceutical biology.

[19]  Jiming Xiang,et al.  Determination of Five Major 8-Prenylflavones in Leaves of Epimedium by Solid-Phase Extraction Coupled with Capillary Electrophoresis. , 2016, Journal of Chromatographic Science.

[20]  K. Kim,et al.  Design of a RANK-Mimetic Peptide Inhibitor of Osteoclastogenesis with Enhanced RANKL-Binding Affinity , 2016, Molecules and cells.

[21]  X. Jia,et al.  Metabolite Profiles of Icariin in Rat Feces, Bile and Urine by Ultraperformance Liquid-Chromatography/Quadrupole-Time-of-Flight Mass Spectrometry. , 2016, Journal of chromatographic science.

[22]  J. Puzas,et al.  Elevated Lifetime Lead Exposure Impedes Osteoclast Activity and Produces an Increase in Bone Mass in Adolescent Mice. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  Jie Song,et al.  Beneficial Effects of a Flavonoid Fraction of Herba Epimedii on Bone Metabolism in Ovariectomized Rats , 2016, Planta Medica.

[24]  W. Jiang,et al.  Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro , 2016, International journal of oncology.

[25]  Dongwei Zhang,et al.  Herba Epimedii: An Ancient Chinese Herbal Medicine in the Prevention and Treatment of Osteoporosis. , 2015, Current pharmaceutical design.

[26]  A. Bogacz,et al.  The RANKL/RANK/OPG signal trail: significance of genetic polymorphisms in the etiology of postmenopausal osteoporosis. , 2016, Ginekologia polska.

[27]  Peter Zioupos,et al.  The micro-architecture of human cancellous bone from fracture neck of femur patients in relation to the structural integrity and fracture toughness of the tissue , 2015, Bone reports.

[28]  Rong Wang,et al.  Bone marrow ablation demonstrates that estrogen plays an important role in osteogenesis and bone turnover via an antioxidative mechanism. , 2015, Bone.

[29]  Na‐Ra Han,et al.  Glutamic acid ameliorates estrogen deficiency-induced menopausal-like symptoms in ovariectomized mice. , 2015, Nutrition research.

[30]  Jin-jian Lu,et al.  Chemical Constituents, Quality Control, and Bioactivity of Epimedii Folium (Yinyanghuo). , 2015, The American journal of Chinese medicine.

[31]  X. Shi,et al.  Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis. , 2015, Genetics and molecular research : GMR.

[32]  X. Jia,et al.  Metabolic profiling of isomeric aglycones central-icaritin (c-IT) and icaritin (IT) in osteoporotic rats by UPLC-QTOF-MS. , 2015, Drug testing and analysis.

[33]  Zhenhai Zhang,et al.  Mechanism of enhanced antiosteoporosis effect of circinal–icaritin by self-assembled nanomicelles in vivo with suet oil and sodium deoxycholate , 2015, International journal of nanomedicine.

[34]  X. Jia,et al.  The Antiosteoporotic Activity of Central-Icaritin (CIT) on Bone Metabolism of Ovariectomized Rats , 2014, Molecules.

[35]  Qianying Chen,et al.  Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor. , 2014, European journal of pharmacology.

[36]  X. Jia,et al.  Ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry analysis of icariside II metabolites in rats , 2014, Natural Product Research.

[37]  J. Gallagher,et al.  Prevention and treatment of postmenopausal osteoporosis , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[38]  Xiao-Bin Jia,et al.  [Two-dimensional zebrafish model combined with hyphenated chromatographic techniques for evaluation anti-osteoporosis activity of epimendin A and its metabolite baohuoside I]. , 2014, Yao xue xue bao = Acta pharmaceutica Sinica.

[39]  L. Qin,et al.  A Novel Semisynthetic Molecule Icaritin Stimulates Osteogenic Differentiation and Inhibits Adipogenesis of Mesenchymal Stem Cells , 2013, International journal of medical sciences.

[40]  Zhenhai Zhang,et al.  Metabolite profiles of epimedin B in rats by ultraperformance liquid chromatography/quadrupole-time-of-flight mass spectrometry. , 2013, Journal of agricultural and food chemistry.

[41]  Xueting Cai,et al.  [Establishment of zebrafish osteopenia model induced by dexamethasone]. , 2013, Yao xue xue bao = Acta pharmaceutica Sinica.

[42]  B. Sarvari,et al.  Detection of Bone Metastases in Breast Cancer (BC) Patients by Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b), a Bone Resorption Marker and Serum Alkaline Phosphatase (ALP), a Bone Formation Marker, in Lieu of Whole Body Skeletal Scintigraphy with Technetium99m MDP , 2013, Indian Journal of Clinical Biochemistry.

[43]  Young In Park,et al.  Estrogenic/antiestrogenic activities of a Epimedium koreanum extract and its major components: in vitro and in vivo studies. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[44]  S. Kohli,et al.  Role of RANKL–RANK/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications , 2011, Indian journal of endocrinology and metabolism.

[45]  D. Hao,et al.  The genus Epimedium: an ethnopharmacological and phytochemical review. , 2011, Journal of ethnopharmacology.

[46]  M. Payet,et al.  TRPV-5 Mediates a Receptor Activator of NF-κB (RANK) Ligand-induced Increase in Cytosolic Ca2+ in Human Osteoclasts and Down-regulates Bone Resorption*♦ , 2010, The Journal of Biological Chemistry.

[47]  Su-min Chen,et al.  [The OPG/RANKL/RANK system and bone resorptive disease]. , 2003, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

[48]  J. Parham,et al.  Expression, purification, and characterization of the human receptor activator of NF-kappaB ligand (RANKL) extracellular domain. , 2000, Protein expression and purification.

[49]  A. Adinoff,et al.  Steroid-induced fractures and bone loss in patients with asthma. , 1983, The New England journal of medicine.

[50]  Vlad I. Morariu,et al.  Expression , 2015, Principles of Molecular Virology.